Activin and Inhibin

Cathepsin C-IN-5 (compound SF38) is a potent, selective and orally active Cathepsin C inhibitor with IC 50 s of 59.9 nM, 4.26 µM, &gt:5 µM, &gt:5 µM, &gt:5 µM for Cat C, Cat L, Cat S, Cat B, Cat K, respectively. Cathepsin C-IN-5 inhibits the Cat C

Cathepsin C-IN-5 (compound SF38) is a potent, selective and orally active Cathepsin C inhibitor with IC 50 s of 59.9 nM, 4.26 µM, &gt:5 µM, &gt:5 µM, &gt:5 µM for Cat C, Cat L, Cat S, Cat B, Cat K, respectively. Cathepsin C-IN-5 inhibits the Cat C

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC 50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxicForm:SolidIC50&amp: Target:IC 50 : 7.13 µM (Cathepsin X).

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC 50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxicForm:SolidIC50&amp: Target:IC 50 : 7.13 µM (Cathepsin X).

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC 50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxicForm:SolidIC50&amp: Target:IC 50 : 7.13 µM (Cathepsin X).

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC 50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxicForm:SolidIC50&amp: Target:IC 50 : 7.13 µM (Cathepsin X).

Cathepsin X-IN-1 (compound 25) is a potent Cathepsin X inhibitor with an IC 50 of 7.13 µM. Cathepsin X-IN-1 decreases PC-3 cell migration with low cytotoxicForm:SolidIC50&amp: Target:IC 50 : 7.13 µM (Cathepsin X).

Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research.In VitroCavosonstat (N91115), a CFTR modulator, promotes cystic fibrosis

Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research.In VitroCavosonstat (N91115), a CFTR modulator, promotes cystic fibrosis

Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research.In VitroCavosonstat (N91115), a CFTR modulator, promotes cystic fibrosis

Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. Cavosonstat is a CFTR stabilizer, and can be used for cystic fibrosis research.In VitroCavosonstat (N91115), a CFTR modulator, promotes cystic fibrosis

CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC 50 value of 12 nM. CAY10650 suppresses lipid droplets formation and PGE2 secretion.In VitroCAY10650 (12 nM: 30 min: neutrophils) inhibits the expression of the